Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: A review

被引:320
作者
Dieperink, E
Willenbring, M
Ho, SB
机构
[1] VA Med Ctr, Dept Psychiat 116A, Minneapolis, MN 55417 USA
[2] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA
关键词
D O I
10.1176/appi.ajp.157.6.867
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: Neuropsychiatric symptoms are commonly associated with chronic hepatitis C virus infection, its sequelae, and its treatment. In particular, interferon, a primary component of treatment for chronic hepatitis C, has been strongly associated with depressive symptoms. This review summarizes current knowledge about the etiology, course, and treatment of neuropsychiatric problems associated with hepatitis C and interferon alpha (IFN-a) treatment. Method: Studies were identified by computerized searches, and further references were obtained from bibliographies of the reviewed articles. Results: Chronic infection with the hepatitis C virus is a common and growing problem, often affecting persons with psychiatric and substance use problems. Although changes in cognition, mood, and personality have been described in association with hepatitis C and with IFN-a treatment, there has been little systematic study of these changes. Conclusions: Psychiatrists should become familiar with the clinical spectrum associated with hepatitis C virus infection as well as the neuropsychiatric symptoms related to hepatitis C and IFN-alpha treatment. More studies are necessary to define the neuropsychiatric syndromes associated with this population and to find possible effective treatments. Furthermore, research is needed so that patients with psychiatric problems are not excluded from effective treatments for this growing medical problem.
引用
收藏
页码:867 / 876
页数:10
相关论文
共 106 条
  • [1] NEUROPSYCHIATRIC MANIFESTATIONS OF HUMAN-LEUKOCYTE INTERFERON THERAPY IN PATIENTS WITH CANCER
    ADAMS, F
    QUESADA, JR
    GUTTERMAN, JU
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 252 (07): : 938 - 941
  • [2] A phase I trial of intermittent high-dose alpha-interferon and dexamethasone in metastatic renal cell carcinoma
    Amato, R
    Meyers, C
    Ellerhorst, J
    Finn, L
    Kilbourn, R
    Sella, A
    Logothetis, C
    [J]. ANNALS OF ONCOLOGY, 1995, 6 (09) : 911 - 914
  • [3] DEXAMETHASONE INHIBITION OF INTERFERON-ALPHA-2-INDUCED STIMULATION OF CORTISOL AND GROWTH-HORMONE SECRETION IN CHRONIC MYELOPROLIFERATIVE SYNDROME
    BARBARINO, A
    COLASANTI, S
    CORSELLO, SM
    SATTA, MA
    DELLACASA, S
    ROTA, CA
    TARTAGLIONE, R
    BARINI, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (04) : 1329 - 1332
  • [4] AN INVENTORY FOR MEASURING DEPRESSION
    BECK, AT
    ERBAUGH, J
    WARD, CH
    MOCK, J
    MENDELSOHN, M
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 1961, 4 (06) : 561 - &
  • [5] BENKELFAT C, 1994, ARCH GEN PSYCHIAT, V51, P687
  • [6] Benvegnù L, 1998, CANCER-AM CANCER SOC, V83, P901, DOI 10.1002/(SICI)1097-0142(19980901)83:5<901::AID-CNCR15>3.0.CO
  • [7] 2-Z
  • [8] HUMAN-LEUKOCYTE INTERFERON - STRUCTURAL AND BIOLOGICAL RELATEDNESS TO ADRENOCORTICOTROPIC HORMONE AND ENDORPHINS
    BLALOCK, JE
    SMITH, EM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (10): : 5972 - 5974
  • [9] Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy
    Bonkovsky, HL
    Woolley, JM
    [J]. HEPATOLOGY, 1999, 29 (01) : 264 - 270
  • [10] THE EFFECT OF EXERCISE ON DEPRESSION, ANXIETY AND OTHER MOOD STATES - A REVIEW
    BYRNE, A
    BYRNE, DG
    [J]. JOURNAL OF PSYCHOSOMATIC RESEARCH, 1993, 37 (06) : 565 - 574